NOVEL TECHNOLOGIES TO ADDRESS THE LOWER MOTOR NEURON INJURY AND AUGMENT RECONSTRUCTION IN SPINAL CORD INJURY





Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants

Abstract Background "Evergreening" refers to the numerous strategies whereby owners of pharmaceutical products use patent laws and minor drug modifications to extend their monopoly privileges on the drug.We aimed to evaluate the impact of evergreening through the case study of the antidepressant citalopram and its chiral switch form escitalopram by

read more